Investigational oral GLP-1 candidate aimed at delivering injectable-class results in tablet form.
Typical dose range: Trial-stage
Frequency: Daily
Route: Oral
Half-life: Investigational
Evidence level: Early research
Early-stage research compound. No standardised member protocols yet — included for completeness in the GLP-1 reference library.